Dose Delivery Verification by Safai, S.
Dose Delivery Verification 
S. Safai 
Paul Scherrer Institut, Villigen, Switzerland 
Abstract 
This paper focuses on some dosimetry aspects of proton therapy and pencil 
beam scanning based on the experience accumulated at Paul Scherrer Institute 
(PSI). The basic formalism for absolute dosimetry in proton therapy is 
outlined and the two main techniques and equipment to perform the primary 
beam monitor chamber calibration are presented. Depth–dose curve and 
lateral beam width measurements are exposed and discussed in detail, with 
particular attention to the size of the ionization chamber and the characteristic 
of scintillating–CCD dosimetry systems, respectively. It is also explained how 
the angular–spatial distribution of individual pencil beams can be determined 
in practice. The equipment and the techniques for performing regular 
machine-specific quality checks are focused on (i) output constancy checks, 
(ii) pencil beam position and size checks and (iii) beam energy checks. 
Finally, patient-specific verification is addressed.             
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1 Introduction 
Dosimetry plays an essential role in the clinical activities of any centre that offers radiation therapy as 
a modality to treat patients afflicted by tumours. After the installation and tuning of any treatment unit, 
dosimetry is necessary first to accept and then to characterize such a unit in what are typically referred 
to as acceptance and clinical commissioning, respectively. After a successful conclusion of the 
commissioning phase, dosimetry is then required on a regular basis as part of the quality assurance 
programme. As part of that programme, dosimetric quality and consistency checks are typically repeated 
on a daily, weekly, monthly and yearly basis to provide the confidence that the system is behaving as 
expected. Particle-therapy centres are not an exception and adhere strictly to this well-established 
practice. 
In our overview on dosimetry in particle therapy we will follow the sequence outlined above by 
first looking into the dosimetry equipment and techniques for clinical commissioning (Sections 2 and 
3) and then into those for periodic checks (Section 4) with particular attention to those aspects relevant 
to proton therapy and pencil beam scanning (PBS). 
2 Absolute dosimetry 
The most relevant task of absolute dosimetry at commissioning is the calibration of the primary beam 
monitor chamber (BMC). The primary beam monitor chamber—usually a large parallel-plate ionization 
chamber situated in the nozzle of a gantry—is typically calibrated in terms of monitor units (MUs) per 
dose–area product (MU/DwA) or alternatively in terms of MUs per proton (MU/p) [1]. The preferred 
choice is, to a large extent, dictated by the requirements of the treatment planning system (TPS), which, 
to produce a desired dose distribution, could predict either the dose per pencil beam (most commercially 
available TPSs) or the number of protons per pencil beam (e.g. the in-house TPS PSIPLAN of PSI). The 
former would require a MU/DwA calibration that could be derived with ionization chamber 
measurements based on IAEA TRS-398 [2], the latter a MU/p calibration that could be derived with 
Faraday cup measurements. In what follows we will first review the basics of the TRS-398 Code of 
Practice for protons and then explain the two major techniques to calibrate the BMC.      
2.1 Code of practice: the basic formalism 
ICRU 78 [3] adopted the IAEA TRS-398 Code of Practice for reference dosimetry in proton therapy. 
The reader is therefore referred to the latter for a comprehensive overview of reference dosimetry in 
particle therapy. What follows is a short overview from that report.  
The basic formalism according to TRS-398 described the absorbed dose to water Dw,Q for a beam 
quality Q in the following way:  
 𝐷𝐷w,𝑄𝑄 = 𝑀𝑀𝑄𝑄𝑁𝑁𝐷𝐷,w,𝑄𝑄0𝑘𝑘𝑄𝑄,𝑄𝑄0 .                   (1) 
Here MQ is the instrument reading at user beam quality Q, corrected for all influence quantities, 
𝑁𝑁𝐷𝐷,w,𝑄𝑄0 is the absorbed dose to water calibration coefficient for calibration beam quality Q0 (usually 
60Co) and 𝑘𝑘𝑄𝑄,𝑄𝑄0 is the beam quality factor to correct for effects of differences between calibration beam 
quality Q0 and user beam quality Q.  
As primary standard laboratories have no, or very limited, access to proton beams, the reference 
beam quality remains 60Co and the values for 𝑘𝑘𝑄𝑄,𝑄𝑄0 tabulated in TRS-398 for protons are derived by 
calculation rather than experimentally, which introduces additional uncertainties in reference dosimetry 
with protons.   
Typically reference dosimetry in a proton beam is performed by measuring the dose with 
cylindrical ionization chambers placed in the plateau region of a spread-out Bragg peak (SOBP). The 
beam quality index for the proton beam is defined as the residual range Rres in g/cm2 at a measurements 
depth z, with 
 𝑅𝑅res = 𝑅𝑅p − 𝑧𝑧. (2) 
Here Rp is the practical range, i.e. the depth at which the absorbed dose beyond the Bragg peak 
falls to 10% of its maximum value.  
2.2 Beam monitor chamber calibration     
2.2.1 With ionization chambers 
To calibrate the BMC, the use of SOPBs, even though it is the standard for reference dosimetry, may 
not be advisable for proton pencil beam scanning under certain conditions, as first pointed out by Jäkel 
et al. [4] for heavy ions. In fact, its applicability depends on the location of the energy modulation system 
along the beam line with respect to the BMC, as explained below.  
(a) If the energy modulation is performed downstream from the BMC, for instance with the use 
of range shifters in the nozzle, then the BMC will always ‘see’ the same energy for all the 
energy layers delivered in a given SOBP. As such, only one calibration value has to be 
determined for a given energy tune. In this case BMC calibration with reference dosimetry in 
the middle of SOBPs is applicable and should be performed for every energy tune. 
(b) If, on the other hand, the energy modulation is performed upstream from the BMC, for 
instance with the use of a degrader just after the accelerator, then the BMC will ‘see’ different 
energies, a different one for every energy layer in a given SOBP. Since, in this case, each 
energy layer corresponds to a different energy tune, the calibration has to be performed 
individually for every deliverable energy or at least for a subset of deliverable energies. 
Hence, the BMC calibration with reference dosimetry in the middle of SOBPs is not advisable 
in this case. A much more practical approach is the calibration performed with use of small 
parallel-plate ionization chambers (e.g. Markus chambers) placed at shallow depth in water, 
e.g. at z equal to 2 g/cm2, in the middle of a 10 × 10 cm2 monoenergetic energy layer, to be 
repeated for all, or a subset of, deliverable energies. Equation (2) is then used to compute the 
beam quality index for a given energy layer in order to extract the corresponding 𝑘𝑘𝑄𝑄,𝑄𝑄0. With 
this method parallel-plate ionization chambers are preferred to cylindrical chambers since the 
measurements are performed in a gradient region. As such, particular attention should be 
given in positioning the chambers at the desired depth z.           
2.2.2 With Faraday cups 
The use of Faraday cups is the direct way to calibrate the BMC in terms of MU/p.  
Typically the Faraday cup is placed at the exit of the nozzle in air. All energy tunes, or a subset 
of deliverable energy tunes, are individually delivered. After delivery, the number of protons is 
determined directly by the measured charge in the Faraday cup; this number is recorded together with 
the number of MUs registered by the BMC for a given energy. The ratio between the two numbers will 
then provide the calibration.       
 
 
Fig. 1: Comparison between a BMC calibration performed with a Faraday cup and the calibration performed with 
ionization chambers [1]. 
At Paul Scherrer Institut (PSI) we compared the calibration performed with a Faraday cup with 
the calibration derived with different ionization chambers (Fig. 1). The calibrations agree within 3%. 
Details of this comparison have been published by Gomà et al. [1].   
2.2.3 Validation 
Regardless of the method used to calibrate the BMC, reference dosimetry in SOBPs following TRS-398 
remains a valuable way to validate the calibration determined with that particular method and to 
introduce additional correction factors if a significant discrepancy is observed. As an example, at PSI 
we opted for the Faraday cup method in Gantry 2, which has an upstream energy modulation system as 
described in Section 2.2.1(b). After the BMC calibration with the Faraday cup, the dose was verified 
following TRS-398 in the middle of several SOPBs located at different depths. The difference between 
the measured dose and the expected one was then used to introduce an energy-dependent correction 
factor in the calibration.   
3 Relative dosimetry 
At clinical commissioning relative dosimetry plays an essential role in the collection of the reference 
dosimetric beam data required by the TPS for dose calculations. The type and quantity of the data to be 
collected depend on the requirement of a specific TPS. In general, a comprehensive set of pencil beam 
integral depth–dose curves and lateral beam widths (i.e. spot sizes) is needed, typically measured for a 
subset of the deliverable energies. We will illustrate the type of equipment and techniques to perform 
such measurements. 
3.1 Depth–dose curve measurements 
Integral depth–dose curves for monoenergetic pencil beams are usually measured with large circular 
parallel-plate ionization chambers with a diameter (∅) of at least 8 cm. These chambers have an 
excellent resolution in depth and are large enough to collect the dose deposited by both primary and 
secondary particles. The chamber is placed in a water tank and while a pencil beam is delivered, either 
with constant beam ON or on a spot-by-spot basis, the chamber is moved along the beam axis to measure 
the entire Bragg peak curve (Fig. 2). At each position in depth the integral signal measured by the 
chamber is recorded and later normalized with either the MU measured by the BMC or the signal from 
a large reference chamber positioned at the entrance of the tank. 
 
 
Fig. 2: Experimental set-up at PSI Gantry 2 for range measurements in water 
A question that is often asked is what should be the ideal size of the chamber for such 
measurements. Figure 3 shows in a logarithmic scale the lateral profile of a pencil beam measured at 
mid range in water for a 150 MeV pencil beam. The primary protons contribute mainly to the central 
envelope of the distribution and can be well described with a Gaussian function (the first Gaussian in 
the plot). The sigma of this function is often used to characterize the lateral pencil beam width (also 
referred to as ‘spot size’). The secondary particles, as a result of nuclear interactions of the primary 
beam in the medium, deposit dose not only in the central envelope but also outside that region and create 
a so-called halo of deposited dose around the primary beam. The halo is mainly produced by large 
scattered secondary protons. In its most simplistic form the halo can also be described with a Gaussian 
function but with a significantly larger sigma [5]. The sigma of this second Gaussian could be up to 2-
cm large [5]. Figure 3 shows that the second Gaussian can well describe the beam halo up to 4 cm from 
the central axis. Beyond that point there could be additional dose deposited that would need a better 
mathematical description. From this we learn that an 8-cm (∅) circular ionization chamber could miss 
some of the dose deposited at larger radius and that a wider chamber could be advisable. On the other 
hand, if a treatment planning system is unable to properly describe the additional dose deposited outside 
that boundary, e.g. if only a two-Gaussian model is implemented, then an 8-cm chamber could be 
sufficient and the use of a larger one could be counterproductive. Hence, the answer to the original 
question is not so straightforward and depends also on how well the TPS is able to describe the halo. At 
PSI we decided to use an 8-cm chamber. Figure 4 shows the comparison between 8-cm and a 12-cm 
chambers for five different energies measured at PSI. A small but significant difference is observed only 
at mid range for high-energy beams.    
 
 
Fig. 3: Transversal profile of a 150 MeV pencil beam measured in water at mid range 
3.2 Lateral beam width measurements 
In this section first a brief exposure of the fundamentals of pencil beam propagation in air is given 
followed by how to determine in practice the spot size and angular–spatial distribution of individual 
pencil beams.   
 
  
Fig. 4: Depth–dose curves measured in water with 8-cm and 12-cm-large parallel-plate ionization chambers 
3.2.1 Pencil beam propagation in air: generalized Fermi–Eyges theory 
Generally the beam optic of a PBS gantry is designed and tuned to bring the waist of the beam as close 
as possible to the gantry isocentre, i.e. the spot is smallest at isocentre. In reality multiple Coulomb 
scattering (MCS) in the nozzle and air moves the waist further upstream from the isocentre, in particular 
for low-energy beams, for which MCS is more pronounced. As the lateral size of an individual pencil 
beam changes as the beam propagates in air, a unique value to describe the size of such a beam is, in 
general, not sufficient. Generalized Fermi–Eyges theory can well describe the propagation of a pencil 
beam in air by parametrizing the angular–spatial distribution of the pencil beam with three parameters, 
the so-called moments of the distribution, A0, A1 and A2 [6, 7]. The angular–spatial distribution, ASD, 
represents the Eyges solution to Fermi’s diffusion equation and can be described as follows (for the x 
coordinate):  
 
 ASD𝑥𝑥(𝑥𝑥,𝜃𝜃, 𝑧𝑧) = 1
𝜋𝜋�𝐴𝐴0𝐴𝐴2−𝐴𝐴1
2
e−�𝐴𝐴0𝑥𝑥2−2𝐴𝐴1𝑥𝑥𝑥𝑥+𝐴𝐴2𝑥𝑥2��𝐴𝐴0𝐴𝐴2−𝐴𝐴12� . (3) 
Here ASDx describes the distribution of the protons within a spot both in angle and in position 
projected onto the x–z plane at a given longitudinal position z. In general, A0, A1 and A2 are a function 
of z and they represent the doubled angular variance, doubled covariance and doubled spatial variance, 
respectively. Hence, we can write  
 
 𝐴𝐴0(𝑧𝑧) = 2𝜎𝜎𝜃𝜃2(𝑧𝑧), (4) 
 𝐴𝐴1(𝑧𝑧) = 2Cov(𝑥𝑥, 𝜃𝜃, 𝑧𝑧), (5) 
 𝐴𝐴2(𝑧𝑧) = 2𝜎𝜎𝑥𝑥2(𝑧𝑧), (6) 
where σx and σθ is the spatial and angular spreads, respectively. As in general the multiple Coulomb 
scattering in air is small, the propagation of the beam at the exit of the nozzle and in the proximity of 
the isocentre can be expressed as it would propagate in vacuum, i.e.  with  
 
 𝐴𝐴2(𝑧𝑧) = 𝐴𝐴0,0𝑧𝑧2 + 2𝐴𝐴1,0𝑧𝑧+ 𝐴𝐴2,0, (7) 
where A0,0, A1,0 and A2,0 represent the initial moments of the distribution at the reference position 𝑧𝑧 = 0. 
When A2(z) is known, then the spot size (expressed with σx) at a given position z can be computed with 
Eq. (6), i.e. 
 𝜎𝜎𝑥𝑥 = �𝐴𝐴2(𝑧𝑧)/2. (8) 
3.2.2 Angular–spatial distribution determination in practice 
Nowadays treatment planning systems can describe the beam propagation in air with Eq. (7) or with 
similar equations. From Eq. (7), we learn that the doubled spatial variance A2 is a quadratic function of 
z and that the initial moments are the coefficients of this function. 
Experimentally the coefficients are determined by measuring A2 at, at least, three different planes 
in z. A quadratic fit to the measured A2 as a function of z will provide the coefficients, i.e. the initial 
moments of the angular distribution, which will be used by the TPS to predict the spot size at any other 
plane in air via Eqs. (7) and (8) (see Fig. 5). The values of A2 for the fit are typically determined 
experimentally by measuring high-resolution 2D lateral profiles of individual pencil beams at those 
planes. A 2D Gaussian fit is then performed on the 2D lateral profiles to obtain σx and σy. Equation (6) 
and the analogous equation for y are then used to compute A2 at those planes.    
 
 
Fig. 5: Double spatial variance A2 for a 150 MeV pencil beam measured in air at PSI Gantry 2 (dots), and the 
quadratic fit through the solid lines. The black dashed line shows the nozzle contribution due to the MCS of the 
nozzle alone. The dashed coloured lines are derived from the difference between the fit and the nozzle contribution 
and can be interpreted as the propagation of A2 due to the beam optic alone.    
For this kind of measurement it is advisable to use high-resolution detectors, such as scintillating 
screens or Gafchromic films (e.g. EBT3). Scintillating screens are usually used in combination with a 
mirror and a CCD; therefore hereafter we will refer to this equipment as scintillating–CCD dosimetry 
systems (Fig. 6).    
 
 
 
Fig. 6: Scintillating–CCD dosimetry system at PSI Gantry 1 (left) and a schematic representation (right) 
It should be noted that the response of both Gafchromic films and scintillating screens depends 
on the energy and the linear energy transfer (LET – the energy transferred to the medium per unit of 
path length) [8, 9]. The response decreases with decreasing energy and increasing LET. Therefore, a 
pencil beam depth– dose curve measured with such systems shows a supressed Bragg peak compared 
to a curve measured with ionization chambers. This phenomenon is documented in the literature and 
has been often called the quenching effect. The quenching effect is irrelevant for transversal dose 
distribution measurements when the energy spectrum across the measurement plane can be assumed 
constant, which is generally the case for spot-size determination in air [10].    
Scintillating–CCD systems have the advantage compared to Gafchromic films to be linear with 
dose and to have an electronic readout providing faster and more accurate results. With these systems a 
large quantity of data can be recorded and analysed almost simultaneously, representing one of the most 
efficient ways of collecting the necessary dosimetric data at commissioning.    
4 Periodic checks 
4.1 Machine-specific dosimetry 
For PBS there are three main important dosimetry aspects that have to be verified constantly, on a daily, 
monthly and yearly basis, i.e.: 
i. absolute dose (output constancy check); 
ii. pencil beam position and size (including alignment at isocentre); 
iii. beam energy (range measurements). 
The rationale for these checks is to identify as early as possible problems with: (i) the monitor 
calibration and/or in general with the system, (ii) the scanning system and/or beam line optic and (iii) 
the energy selection system and/or beam line.  
4.1.1 Output constancy checks 
Output constancy checks are typically performed with reference ionization chambers, either in a 
phantom (daily checks) or in water (yearly checks), in the middle of flat dose distributions (i.e. SOBPs).    
4.1.2 Pencil beam position and size checks 
Scintillating–CCD systems, strip chambers, Gafchromic films and amorphous-Si detectors are among 
the devices that can be used to perform constancy checks of the beam size and of the accuracy of beam 
positioning. Compact systems like strip chambers could be used on a daily basis, while larger systems 
like the scintillating–CCD systems could be employed on a monthly or yearly basis, even though it is 
difficult to generalize. As a matter of fact, there are now new commercial products coming to the market 
designed to use scintillating–CCD systems for daily quality assurance, which are quite promising. 
The performance of the scanning system, i.e. the accuracy of pencil beam positioning, is probably 
the one more prone to changes over time than any other system (e.g. energy-selection system); at least, 
this is our experience at PSI. The accuracy of beam positioning is typically gantry angle and energy 
dependent and could fluctuate from day to day. It could also depend on the ramping scheme of the beam 
line and the sequence in which the energy layers are delivered. Therefore, particular attention should be 
given to the frequency and comprehensiveness of the consistency checks for this system. Both the 
alignment of the beam at isocentre should be verified (absolute beam position) as well as the relative 
position between neighbouring spots. The homogeneity of large energy layers is quite sensitive to the 
precision of the placement of the individual pencil beams within the layers. Hence, the delivery of such 
layers in air, covering the lateral extent of the scanning region, on a 2D high-resolution detector (e.g. 
scintillating–CCD system), is an effective way to verify the performance of the scanning system.            
4.1.3 Beam energy checks 
The energy is indirectly checked by verifying the range and/or the shape of the Bragg curve. Range 
measurements in water as described in Section 3.1 are time consuming and are usually repeated only on 
a yearly basis. Multilayer ionization chambers (MLICs), on the other hand, can record a full Bragg curve 
extremely fast in a single measurement [11]. If, on top of that, the MLIC can be synchronized with the 
beam delivery then hundreds of energies could be measured in a few minutes. MLICs are cross-
calibrated against measurements in water and the reproducibility of the measured range is very high, 
well below the typical tolerance of 1 mm for range checks. If well integrated, a MLIC could be a 
powerful tool to perform daily range measurements or it can be employed for comprehensive weekly or 
monthly checks. 
The use of wedges in combination with 2D detectors (e.g. scintillating–CCD systems) is another 
alternative to perform energy checks, even though the number of energies that can be verified in the 
same session is small. Another method is to look at the ratio of the signal measured by at least two small 
detectors (ionization chambers or diodes) placed at different depths. The ratio is than compared to a 
reference value, which is characteristic for a given energy.              
4.2 Patient-specific dosimetry 
Patient-specific verifications are typically performed by measuring 2D dose profiles at different planes 
with 2D arrays of ionization chambers in phantoms. For comparison the planned dose is recalculated 
for that particular phantom and geometry used during verification. Sometimes 2D arrays are only used 
to verify the relative dose distribution. In this case, the absolute dose is additionally verified with 
calibrated ionization chambers (e.g. pin-point chambers) in a water phantom for one of a few selected 
reference points. The field under consideration would have to be applied at least twice, one for relative 
and one for absolute dose verification. Ideally the dose should be verified under the proper treatment 
gantry angle for that field, but this would require a rotatable phantom. When a rotatable phantom is not 
available, then, on top of the field verification under a reference angle, it is advisable to run the field 
also under the treatment angle but without performing a dose measurement, just to verify that the field 
is deliverable. This is for the reasons pointed out in Section 4.1.2; the dedicated monitor in the nozzle 
could identify potential problems of spot positioning for that field. 
Each individual field is typically verified and the output corrected if a discrepancy is observed 
between measured and planned doses. At PSI, only after several years of experience and improvements 
in the in-house dose calculation engine did we reach the confidence to drop the verification of every 
individual field planned for Gantry 1. On the other hand, Gantry 2 has been in operation only for a few 
years and, therefore, as of now, all planned fields for this gantry are being verified.                
4.2.1 Log file analysis 
Dose calculations based on the parameters registered in log files during beam delivery, such as spot 
position and delivered MUs, could become a relevant tool in the verification of the delivered dose and 
could reduce the amount of measurements to be performed for each planned field prior to the treatment 
[12]. This approach could also verify on a daily basis the delivered dose and could therefore be used to 
adapt the treatment if necessary.      
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